Rheumatologists News and Research

RSS

Methotrexate appears to facilitate bone remodeling in patients with osteoarthritis

According to new research findings presented at the 2019 ACR/ARP Annual Meeting, methotrexate did not demonstrate superior efficacy over placebo for pain relief and function evolution at three and 12 months in patients with erosive hand osteoarthritis.

11 Nov 2019

Psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis

In a new study presented at the 2019 ACR/ARP Annual Meeting, researchers found that the age of psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis.

11 Nov 2019

Optimal therapy for Down syndrome arthropathy remains unclear, reveals study

A new study found that patients with Down syndrome arthropathy continue to have an approximate year-long delay in diagnosis from the onset of their symptoms, and that optimal therapy for this condition remains unclear.

11 Nov 2019

Tocilizumab more effective than rituximab in achieving low disease activity in RA patients

New research discovered that tocilizumab is more effective than rituximab in achieving low disease activity in patients with rheumatoid arthritis whose synovial tissue show a low level of B cell infiltration and did not respond to conventional synthetic disease-modifying anti-rheumatic drugs (conventional synthetic DMARDs) or tumor necrosis factor inhibitors first.

11 Nov 2019

Study shows ADA2 is a sensitive, specific biomarker for macrophage activation syndrome

According to new research findings presented at the 2019 ACR/ARP Annual Meeting, adenosine deaminase 2 (ADA2) in the peripheral blood is a sensitive, specific biomarker for macrophage activation syndrome, a potentially life-threatening complication of systemic juvenile idiopathic arthritis (systemic JIA)

10 Nov 2019

Study provides first data on infectious risk in children exposed to non-TNFi biologics and tofacitinib

A new study found that very few serious infections were seen in children born to mothers with chronic inflammatory diseases who used non-TNFi biologics or tofacitinib during pregnancy compared to children not exposed to these drugs and children exposed to TNFi biologics in utero.

10 Nov 2019

Biologics can be used effectively for both elderly-onset and young-onset RA patients

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, both patients with rheumatoid arthritis whose disease onset occurred at an older age and those whose disease onset occurred earlier in life have similar improvements in clinical disease at 48 weeks after starting biologic disease-modifying antirheumatic drugs, as well as similar drug maintenance and adverse events discontinuation rates.

10 Nov 2019

Additional medications needed to control the symptoms of juvenile idiopathic arthritis

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, there is a profound ongoing need for additional medications to control the signs and symptoms of juvenile idiopathic arthritis, despite the availability of several approved biologic disease-modifying antirheumatic drugs (biologics).

10 Nov 2019

Atmospheric and environmental changes linked to organ-specific lupus flares

New research findings presented at the 2019 ACR/ARP Annual Meeting found a strong association between changes in atmospheric and environmental variables 10 days before a clinic visit and organ-specific lupus flares in patients with systemic lupus erythematosus.

10 Nov 2019

Children with Down syndrome at greater risk of an associated form of arthritis

A new study finds that children with Down syndrome are at an increased risk of an associated form of arthritis.

10 Nov 2019

Study reveals safety, efficacy of live zoster vaccine for people taking TNF inhibitors

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, the live zoster virus vaccine is safe for people who are currently receiving tumor necrosis factor inhibitor (TNFi) biologic therapies for various indications.

10 Nov 2019

Research discovers link between biomarker for RA and industrial air pollutants

New, late-breaking research discovered that there are significant associations between anti-citrullinated protein bodies, a characteristic biomarker for rheumatoid arthritis, and industrial emissions of fine particles matter and sulfur dioxide.

10 Nov 2019

Antibody that targets CXCR6 prevents and reverses multiple sclerosis in mouse model

Multiple sclerosis, an autoimmune disorder, is known to be driven by "helper" T cells, white blood cells that mount an inflammatory attack on the brain and spinal cord. A new study from Boston Children's Hospital pinpoints the specific subgroup of helper T cells that cause MS, as well as a protein on their surface, called CXCR6, that marks them.

4 Oct 2019

New imaging systems can help diagnose heart disease

Researcher and professor Lasse Løvstakken starts a video on his computer screen. We're in the eye of a storm. It looks almost like a hurricane approaching a coastline.

30 Sep 2019

Updated recommendations for treatment of patients with axial spondyloarthritis released

Today, the American College of Rheumatology, in partnership with the Spondylitis Association of America and the Spondyloarthritis Research and Treatment Network, released the 2019 Update of the Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.

22 Aug 2019

Survey: More than 50% of people with arthritis have tried medical marijuana or CBD

On June 13, CreakyJoints, a Global Healthy Living Foundation patient community, will present a poster at the Annual European Congress of Rheumatology meeting in Madrid, Spain. Two additional abstracts were accepted for publication.

20 Jun 2019

Remission of rheumatoid arthritis linked with reduction in cardiovascular complications

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019) demonstrate that remission in patients with rheumatoid arthritis is associated with an 80% reduction in risk of cardiovascular outcomes.

12 Jun 2019

ACR and Arthritis Foundation release two guidelines on juvenile idiopathic arthritis

Today, the American College of Rheumatology, in partnership with the Arthritis Foundation, released two guidelines on juvenile idiopathic arthritis.

30 Apr 2019

ACR praises Representatives Ruiz and Wenstrup for introducing bipartisan step therapy legislation

The American College of Rheumatology today praised Representative Raul Ruiz, MD (D-CA) and Representative Brad Wenstrup, MD (R-OH) for introducing the "Safe Step Act" (H.R. 2279). If enacted, H.R. 2279 would place reasonable parameters around the use of step therapy among employer-sponsored health plans.

12 Apr 2019

ACR releases new drug pricing and step therapy position statements

The American College of Rheumatology has released new drug pricing and step therapy position statements that they hope legislators will consider as they continue to explore policy and regulatory options to make drugs more affordable and accessible.

2 Apr 2019

Rheumatologists News and Research

Methotrexate appears to facilitate bone remodeling in patients with osteoarthritis

Psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis

Optimal therapy for Down syndrome arthropathy remains unclear, reveals study

Tocilizumab more effective than rituximab in achieving low disease activity in RA patients

Study shows ADA2 is a sensitive, specific biomarker for macrophage activation syndrome

Study provides first data on infectious risk in children exposed to non-TNFi biologics and tofacitinib

Biologics can be used effectively for both elderly-onset and young-onset RA patients

Additional medications needed to control the symptoms of juvenile idiopathic arthritis

Atmospheric and environmental changes linked to organ-specific lupus flares

Children with Down syndrome at greater risk of an associated form of arthritis

Study reveals safety, efficacy of live zoster vaccine for people taking TNF inhibitors

Research discovers link between biomarker for RA and industrial air pollutants

Antibody that targets CXCR6 prevents and reverses multiple sclerosis in mouse model

New imaging systems can help diagnose heart disease

Updated recommendations for treatment of patients with axial spondyloarthritis released

Survey: More than 50% of people with arthritis have tried medical marijuana or CBD

Remission of rheumatoid arthritis linked with reduction in cardiovascular complications

ACR and Arthritis Foundation release two guidelines on juvenile idiopathic arthritis

ACR praises Representatives Ruiz and Wenstrup for introducing bipartisan step therapy legislation

ACR releases new drug pricing and step therapy position statements

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News